Oleg Movchan

Insider Reports History

Reporting-owner location: Chicago, IL
Latest reporting-owner signature: /s/ Matthew Campobasso, as Attorney-in-Fact for Oleg Movchan
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Oleg Movchan

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Enfusion, Inc.

Security class: Class A Common Stock
Shares / value: 0
Estimated value: $0
Report date: 21 Apr 2025
Price: $11.15
Ownership: By CSL Tech Holdings, LLC

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Enfusion, Inc.

Security class: Class A Common Stock
Shares / value: 0
Estimated value: $0
Report date: 21 Apr 2025
Price: $11.15
Ownership: Direct

Insider Reports Filed by Oleg Movchan

4

Enfusion, Inc.

Report period: 21 Apr 2025
Transactions: 5
Transaction value: $0
Accepted by SEC: 21 Apr 2025, 17:09
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4

Enfusion, Inc.

Report period: 06 Mar 2025
Transactions: 1
Transaction value: -$130,473
Accepted by SEC: 07 Mar 2025, 18:15
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4

Enfusion, Inc.

Report period: 03 Mar 2025
Transactions: 1
Transaction value: -$32,032
Accepted by SEC: 05 Mar 2025, 18:20
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4

Enfusion, Inc.

Report period: 26 Feb 2025
Transactions: 2
Transaction value: $0
Accepted by SEC: 28 Feb 2025, 16:07
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4

Enfusion, Inc.

Report period: 07 Jan 2025
Transactions: 1
Transaction value: -$28,070
Accepted by SEC: 10 Jan 2025, 16:20
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4

Enfusion, Inc.

Report period: 05 Mar 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 07 Mar 2024, 17:15
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4

Enfusion, Inc.

Report period: 01 Mar 2024
Transactions: 2
Transaction value: +$85,122
Accepted by SEC: 05 Mar 2024, 20:26
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4

Enfusion, Inc.

Report period: 08 Jan 2024
Transactions: 2
Transaction value: -$24,080
Accepted by SEC: 10 Jan 2024, 20:02
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4

Enfusion, Inc.

Report period: 14 Dec 2023
Transactions: 1
Transaction value: -$1,001,000
Accepted by SEC: 18 Dec 2023, 19:00
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4

Enfusion, Inc.

Report period: 01 Dec 2023
Transactions: 1
Transaction value: -$1,513,500
Accepted by SEC: 05 Dec 2023, 19:00
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4

Enfusion, Inc.

Report period: 05 Jan 2023
Transactions: 2
Transaction value: $0
Accepted by SEC: 09 Jan 2023, 16:35
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4

Enfusion, Inc.

Report period: 22 Dec 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 27 Dec 2022, 19:59
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4

Enfusion, Inc.

Report period: 12 Aug 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 12 Aug 2022, 13:02
Role: Director, 10%+ Owner
Next action: Open filing details

4

Enfusion, Inc.

Report period: 11 May 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 13 May 2022, 20:19
Role: Director, 10%+ Owner
Next action: Open filing details

4/A

Enfusion, Inc.

Report period: 25 Oct 2021
Transactions: 1
Transaction value: -$29,015,210
Accepted by SEC: 29 Apr 2022, 17:02
Role: Director, 10%+ Owner
Next action: Open filing details

3/A

Enfusion, Inc.

Report period: 21 Oct 2021
Transactions: 0
Transaction value: $0
Accepted by SEC: 29 Apr 2022, 17:00
Role: Director, 10%+ Owner
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .